Inturrisi, Federica
Early Career Affiliate Board member
Epidemiologist, National Cancer Institute (NCI), USA
Dr. Federica Inturrisi is an epidemiologist with a special interest on cervical cancer prevention.
She holds a bachelor degree in Biology (2011) from the University of Catania, Italy, a master degree in Molecular Biosciences – major Cancer Biology (2014) from the German Cancer Research Center (DKFZ) and the University of Heidelberg, Germany, and a master degree in Epidemiology and Biostatistics (2016) from the Università Cattolica del Sacro Cuore in Rome, Italy. In 2022, she completed her PhD in Epidemiology at VU University Amsterdam, the Netherlands.
Her PhD contributed to the Horizon 2020 RISCC project, focusing on optimizing cervical cancer screening through risk-based strategies in European settings. Her work included evaluating self-sampling as a primary screening method in the Dutch national program and risk stratification based on HPV genotyping, past screening results and HPV vaccination status.
Since 2022, Dr. Inturrisi has been working with the US National Cancer Institute (NIH/NCI) on the PAVE project, driving efforts to advance secondary prevention of cervical cancer in resource-limited settings. As part of this large effort in nine LMICs, Dr. Inturrisi works on the self-sampling and HPV extended genotyping components, contributes to the AI-driven visual evaluation, and supports with coordination of the clinical sites and collaboration with the commercial partners. She also serves as the referent person for study sites in sub-Saharan Africa (Tanzania, Malawi, Eswatini) and spent a year in Tanzania supporting fieldwork and collaborating on national cervical cancer prevention policies.
